1. Home
  2. HALO vs LLYVA Comparison

HALO vs LLYVA Comparison

Compare HALO & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • LLYVA
  • Stock Information
  • Founded
  • HALO 1998
  • LLYVA 1991
  • Country
  • HALO United States
  • LLYVA United States
  • Employees
  • HALO N/A
  • LLYVA N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • LLYVA Broadcasting
  • Sector
  • HALO Health Care
  • LLYVA Industrials
  • Exchange
  • HALO Nasdaq
  • LLYVA Nasdaq
  • Market Cap
  • HALO 7.4B
  • LLYVA 6.0B
  • IPO Year
  • HALO N/A
  • LLYVA N/A
  • Fundamental
  • Price
  • HALO $58.79
  • LLYVA $67.53
  • Analyst Decision
  • HALO Buy
  • LLYVA
  • Analyst Count
  • HALO 9
  • LLYVA 0
  • Target Price
  • HALO $61.63
  • LLYVA N/A
  • AVG Volume (30 Days)
  • HALO 1.8M
  • LLYVA 211.7K
  • Earning Date
  • HALO 05-06-2025
  • LLYVA 01-01-0001
  • Dividend Yield
  • HALO N/A
  • LLYVA N/A
  • EPS Growth
  • HALO 63.33
  • LLYVA N/A
  • EPS
  • HALO 3.43
  • LLYVA N/A
  • Revenue
  • HALO $1,015,324,000.00
  • LLYVA N/A
  • Revenue This Year
  • HALO $20.06
  • LLYVA $7.29
  • Revenue Next Year
  • HALO $24.04
  • LLYVA N/A
  • P/E Ratio
  • HALO $17.14
  • LLYVA N/A
  • Revenue Growth
  • HALO 22.44
  • LLYVA N/A
  • 52 Week Low
  • HALO $37.73
  • LLYVA $32.55
  • 52 Week High
  • HALO $66.00
  • LLYVA $79.63
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.06
  • LLYVA 51.40
  • Support Level
  • HALO $57.50
  • LLYVA $64.92
  • Resistance Level
  • HALO $62.14
  • LLYVA $67.99
  • Average True Range (ATR)
  • HALO 2.90
  • LLYVA 3.53
  • MACD
  • HALO -0.40
  • LLYVA 0.30
  • Stochastic Oscillator
  • HALO 36.41
  • LLYVA 67.35

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.

Share on Social Networks: